Connect with the right partners and unlock new growth opportunities today:- United States: Recent Industry Developments March 2026: Eli Lilly and Company expanded manufacturing capacity for GLP-1 receptor agonists, supporting rising demand for type 2 diabetes and obesity management therapies
I recently had annual blood work and all.of my thyroid reading were well into the normal range but most important I don't feel as tired and sluggish as I did prior to taking Priority One
Intraoperative O-arm Navigation Yields 100% Accuracy in Pedicle Screw Placement for Adolescent Idiopathic Scoliosis: A Single-Institution Study
Gastrointestinal side effects such as nausea, vomiting, and diarrhea are the most commonly reported but typically improve over time
Inducible reporter assays, especially luciferase reporters, which are linked to the activation of specific signaling pathways for example by the GIP receptor, provide a reliable measurement of the inhibitory or activating effect of substances on diabetes-associated cell signaling pathways (Fig
